Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-276139
Filing Date
2023-11-13
Accepted
2023-11-13 16:50:05
Documents
14
Period of Report
2023-09-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d295308d8ka.htm   iXBRL 8-K/A 31807
2 EX-23.1 d295308dex231.htm EX-23.1 2433
3 EX-99.3 d295308dex993.htm EX-99.3 242631
  Complete submission text file 0001193125-23-276139.txt   430644

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bhc-20230929.xsd EX-101.SCH 2521
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20230929_lab.xml EX-101.LAB 18620
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20230929_pre.xml EX-101.PRE 11665
8 EXTRACTED XBRL INSTANCE DOCUMENT d295308d8ka_htm.xml XML 5182
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-14956 | Film No.: 231399692
SIC: 2834 Pharmaceutical Preparations